Suppliers to the industry have been innovating to meet the single-use requirements of biotech manufacturers. Emerson’s Michalle Adkins pointed me to a recent award received for technology innovation for these single-use requirements.
Posts by or with Michalle Adkins
BioPhorum Roadmap for In-line Monitoring and Real-time Release
Emerson’s Michalle Adkins will be presenting, Update on BioPhorum’s Roadmap for In-line Monitoring and Real- Time Release at the conference.
Biopharmaceutical Single Use Measurement and Control
At this past autumn’s Emerson Exchange conference in San Antonio, Texas, Emerson’s Michalle Adkins demonstrated single use manufacturing measurement and control devices and how they could be used to measure and control biomanufacturing operations in a single use environment.
Tracking Cell Therapy Chain of Identity
In this 2:25 YouTube video, Address Cell Therapy Batch Production Challenges with Syncade, Emerson’s Michalle Adkins shares how operations management technology plays an important role in addressing these challenges.
Life Sciences at Emerson Exchange
Emerson Exchange begins in just a few short days. I am quite excited about the Life Sciences relevant content in the exhibit hall this year. We are covering many different technologies including instrumentation, controls, batch processing, process analytical...
Moving to Electronic Batch Records
Yesterday we highlighted advancements in exception management technology for pharmaceutical and biopharmaceutical manufacturers. Exception management is one element in an electronic batch record (EBR). Other elements for the EBR which also have high data integrity...
Technology Trends for Life Sciences Manufacturers
We seem to be fully in the swing of industry conferences. This week is the pharmaceutical and biotech manufacturing industries' INTERPHEX conference in New York City. It: …brings over 11,000 global industry professionals and 650+ leading suppliers together to "Learn...
Our Global Community
Emerson Exchange 365
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.